Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the history and the previous Revision: v3.6.3 entry was removed, updating the study record's release notes.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdds a new revision entry labeled v3.6.3 to the study history, representing an updated version in the history log. It indicates an internal update to the record without altering study data or outcomes.SummaryDifference0.1%

- Check38 days agoChange DetectedA new Study Status entry was added on 2026-06-22 as part of the latest version (Revision: v3.6.2), and the older revision (v3.6.0) from 2026-03-27 was removed. This update reflects refreshed versioning and status-tracking in the study's history.SummaryDifference0.5%

- Check53 days agoChange DetectedNew UI elements 'Check who can join' and 'Find Contact Information' appear, and the revision tag updated to v3.6.0 (replacing v3.5.5). These changes reflect UI and release updates rather than modifications to study data.SummaryDifference0.5%

- Check60 days agoChange DetectedA new revision entry v3.5.5 was added to the study history and the previous revision v3.5.4 was removed.SummaryDifference0.1%

- Check81 days agoChange DetectedThe Record History now includes a new revision entry for v3.5.4 and removes the previous v3.5.3 entry, updating the page's release notes to reflect the latest versioning of the study record.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.